BATTISTIN, LEONTINO
 Distribuzione geografica
Continente #
NA - Nord America 3.348
EU - Europa 381
AS - Asia 217
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.950
Nazione #
US - Stati Uniti d'America 3.345
CN - Cina 160
SE - Svezia 90
FI - Finlandia 84
DE - Germania 61
UA - Ucraina 58
VN - Vietnam 39
IT - Italia 38
GB - Regno Unito 27
IN - India 12
RU - Federazione Russa 7
EU - Europa 4
KR - Corea 4
FR - Francia 3
NL - Olanda 3
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
IE - Irlanda 2
BN - Brunei Darussalam 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HR - Croazia 1
MD - Moldavia 1
PT - Portogallo 1
SG - Singapore 1
Totale 3.950
Città #
Fairfield 504
Woodbridge 438
Ann Arbor 318
Chandler 292
Jacksonville 277
Wilmington 202
Ashburn 191
Seattle 188
Houston 173
Cambridge 147
Princeton 104
Roxbury 56
Beijing 53
San Diego 42
Dong Ket 39
Medford 27
Nanjing 26
New York 26
Boardman 25
Helsinki 25
Des Moines 19
Nanchang 17
Guangzhou 13
Hebei 13
Norwalk 12
Jiaxing 11
Shenyang 11
Novosibirsk 6
London 5
Padova 5
Rome 5
Borås 4
Milan 4
Tianjin 4
Changsha 3
Collecorvino 3
Delhi 3
Falls Church 3
Kilburn 3
Redwood City 3
Washington 3
Carol Stream 2
Dublin 2
Edinburgh 2
Forlì 2
Hangzhou 2
Islington 2
Jinan 2
Kharkiv 2
Montefiore Conca 2
Nowon-gu 2
Ogden 2
Orange 2
Rockville 2
Adliswil 1
Amsterdam 1
Auburn Hills 1
Bandar Seri Begawan 1
Chisinau 1
Chiswick 1
Dallas 1
Denver 1
Fresh Meadows 1
Genova 1
Groningen 1
Lamézia 1
Lappeenranta 1
Lisbon 1
Madrid 1
Munich 1
Paris 1
Portland 1
Prague 1
Pune 1
San Francisco 1
San José 1
Teramo 1
Toronto 1
Valencia 1
Wandsworth 1
Willenhall 1
Zagreb 1
Totale 3.357
Nome #
A method to evaluate capacity and efficiency of water soluble antioxidants as peroxyl radical scavengers 183
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 156
Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology? 123
A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials 116
Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. 107
Vascular cognitive disorder. A biological and clinical overview 105
Effect of high-frequency repetitive transcranial magnetic stimulation on brain excitability in severely brain-injured patients in minimally conscious or vegetative state 97
Neurological complications of celiac disease and autoimmune mechanisms: a prospective study 96
The monosialoganglioside GM1 dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. 94
Free light chains in the CSF in multiple sclerosis. 92
The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. 91
THE EFFECTS OF PROPOFOL ANESTHESIA ON LOCAL CEREBRAL GLUCOSE-UTILIZATION IN THE RAT 88
Apraxia of eyelid closure in autopsy-confirmed vascular progressive supranuclear palsy 87
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells 86
Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum 83
Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function. 83
Aspects on the integrative actions of the brain from neural networks to "brain-body medicine" 83
Behavioral and neurophysiological effects of repetitive transcranial magnetic stimulation on the minimally conscious state: a case study 82
Combined analysis of CSF ßA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's Disease: preliminary data 82
Cerebral glucose metabolism in patients with multiple sclerosis (MS) and clinical or subclinical cognitive impairment 81
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis 81
Anti-heparan sulfate antibodies in neurological disease 80
SPECT imaging of the brain in dementia: follow-up evaluation 80
C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction 71
Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis 69
Cortical atrophy is relevant in multiple sclerosis at clinical onset 68
Thiethylperazine-induced Parkinsonism: in vivo demonstration of dopamine D2 receptors blockade 66
A marker of endothelial inflammation (serum SSAO/VAP-1)is increased in mild Alzheimer's disease 65
Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat. 65
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis 63
Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study 62
The neurobiology of imagination: possible role of interaction-dominant dynamics and default mode network. 62
Cerebral metabolic responses to clomipramine persist only in raphe-hippocampal system of rats pretreated with the specific neurotoxin parachloroamphetamine. 60
The effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiplegic patients undergoing rehabilitation therapy. Stroke, 27, 1221-1214 (1996) 57
Effects of therapy with the acetylcholinesterase inhibitor rivastigmine on spatial and verbal working memory in Alzheimer's disease: A H2150PET study 57
Protocollo diagnostico nella malattia del motoneurone (MND): considerazioni operative 54
Serum lipoprotein profile and APOE genotype in Alzheimer's disease 54
[123I]-IBZM SPET imaging of D2 receptors in Parkinson's disease: relation to therapeutic response. 53
Antibodies to the ganglionic nicotinic acetylcholine receptor in celiac disease 51
Disease activity determines correlated impairment of cognition and subcortical Cerebral blood flow in patients with relapsing-remitting, mildly disabling Multiple Sclerosis. 51
Demonstration of cerebrospinal fluid specific protein after 2-DE. 49
Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis - A comparative study 49
Multiple sclerosis and autoimmune diseases - Epidemiology and HLA-DR association in North-east Italy 49
Subcortical brain functional alterations and congitive disturbances in early RR-MS patients. 47
SPECT imaging in Parkinson’s disease (Pd) and dementia 47
INVECCHIAMENTO CEREBRALE 46
Anti-heparan sulfate antibodies: Possible marker for vascular dementia? 42
Detection of IgG oligovlonal bands in uncencentrated CSF by means of agarose isoelectricfocusing, double immunofixation, peroxidase staining and avidin-biotin amplification. 38
Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM. 37
Neuropathic pain. 36
Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study 35
The effects of fluoxetine on local cerebral glucose utllisation of awake rats 31
Encefalopatie metaboliche e tossiche 30
Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study 30
Autocoscienza e comunicazione. 29
Antibodies to heparan sulfate: clinical correlations in neurological diseases. 25
Improved detection of free light chains in unconcentrated CSF by agarose IEF and avidin-biotin-peroxidase staining. 25
Vascular Dementia 24
Pharmacotherapy of vertigo 17
Totale 3.970
Categoria #
all - tutte 12.215
article - articoli 11.076
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 774
Totale 24.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019301 0 0 0 0 0 0 0 0 0 69 128 104
2019/2020773 135 32 4 51 71 68 61 85 70 99 44 53
2020/2021641 14 102 12 34 32 72 16 60 92 34 92 81
2021/2022734 27 101 107 51 12 67 28 69 21 17 79 155
2022/2023571 121 61 15 70 103 66 3 38 68 0 25 1
2023/2024234 7 56 49 26 13 46 19 14 3 1 0 0
Totale 3.970